From:  - PC Impfstoffe COVID-19 BMG
Ce: COVID-19-vaccines
Subject: AW: BMG/BioNTech Austausch am 29.Dezember - 14 Uhr
Date: Dienstag, 29. Dezember 2020 11:34:20
Attachments: image00L.png
image002.png
image003,png

cc
gerne können wir den Termin heute auch seitens des BMG wahrnehmen.

Beste Grüße

vor @biontech.de>

Gesendet: Montag, 28. Dezember 2020 17:00

Ar: - PG Impfstoffe COVID-19 BMG <TD bmg. bund.de>; COVID-19-
vaccines <COVID-19-vaccines@bmg.bund.de>

Cc: Vo biontech..de>

 

Betreff: BMG/BioNTech Austausch am 29.Dezember - 14 Uhr

Liebe DE liebes BMG-Team,

EEE Bu Eu wir u morgigen em um u m Ersue
itte lassen Sıe uns wissen, ob der Termin auch von Ihrer Seite stattfinden kann.
Vielen Dank und beste Grüße

 

Anschrift:
BioNTech SE

An der Goldgrube 12
55131 Mainz
Germany

Sitz der Gesellschaft: BioNTech SE, An der Goldgrube 12, 55131 Mainz, Germany
Amtsgericht Mainz HRB 48720 - USt.-IdNr. DE 263 382 495 - EoriNr: DE 1070347
Vorstand: Prof. Dr. Ugur Sahin - Sean Marett - Dr. Sierk Poetting - Ryan Richardson - PD Dr. Özlem Türeci

The information contained in this email is intended for the personal and confidential use of the addressee
only. It may also contain privileged information. If you are not the intended recipient then you are hereby
notified that you have received this document in error and that any review, distribution or copying of this
document is strictiy prohibited. If you have received this communication in error, please notify the sender.
Please protect our environment and consider whether you need to print this e-mail.

---This email was Virus checked by UTM 9. http://www.sophos.com---
---This Email was scanned by Sophos UTM system---